Nick Parekh
Principal Scientist Pfizer
Nick Parekh is a Principal Scientist at Pfizer. He earned his Ph.D. in Biomedical Sciences in 2019 from Penn State College of Medicine studying innate immune responses with Dr. Chris Norbury. He did his postdoctoral studies with Dr. Dan Stetson at the University of Washington focusing on innate sensing pathways that contribute to autoimmune disorders. Nick joined Seagen in 2022, which was acquired by Pfizer in 2023.
Seminars
Tuesday 13th October 2026
Deep-Diving Into Mechanistic Insights of a Novel ADC Payload That Inhibits Protein Translation
12:00 pm
- Describing preclinical development of a novel ADC payload targeting protein synthesis
- Evaluating how translation inhibitor ADCs elicit robust anti-tumor activity across a diverse range of tumor types in in vitro and in vivo investigation
- Spotlighting preclinical data to indicate a unique MoA among protein synthesis inhibitors that drives immunogenic cell death
